Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Market Cap	8.62B
Revenue (ttm)	8.39B
Net Income (ttm)	810.95M
Shares Out	168.76M
EPS (ttm)	5.45
PE Ratio	9.37
Forward PE	7.01
Dividend	1.50 (2.94%)
Ex-Dividend Date	Apr 22, 2025

Volume	41,528
Average Volume	279,048
Open	50.32
Previous Close	50.32
Day's Range	50.03 - 51.30
52-Week Range	35.06 - 58.00
Beta	0.35
RSI	48.02
Earnings Date	Aug 13, 2025

About Marinus Pharmaceuticals

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.